Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
03/2010
03/11/2010US20100063275 Process for preparing 6-phenoxypyrimidin-4-ol derivatives in the presence of a quinuclidine or a n-methyl pyrrolidine derivatives
03/11/2010US20100063080 CXCR2 inhibitors
03/11/2010US20100063079 Pyrimidyl Sulphone Amide Derivatives as Chemokine Receptor Modulators
03/11/2010US20100063077 Pyrimidine derivatives for the treatment of amyloid-related diseases
03/11/2010US20100063075 Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives
03/11/2010US20100063073 Methods and Compositions Utilizing Quinazolinones
03/11/2010US20100063044 Substituted aniline derivatives
03/11/2010CA2736281A1 Tri-substituted pyrimidine compounds and their use as pde10 inhibitors
03/11/2010CA2735722A1 Isotopically enriched pyrimidin-5-yl acetic acid derivatives as crth2 antagonists
03/11/2010CA2735420A1 Macrocyclic pyrimidines as protein kinase inhibitors
03/11/2010CA2735208A1 Novel benzamides, production thereof, and use thereof as medicaments
03/11/2010CA2733659A1 Sulfoxime pesticidal compounds and methods related thereto
03/10/2010EP2161259A1 4-Haloalkyl substituted Diaminopyrimidine
03/10/2010EP2160387A2 Heteroarylamide pyrimidone compounds
03/10/2010EP2160381A2 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors
03/10/2010EP1781296B1 Quinazoline derivatives and their use in the treatment of thrombocythemia
03/10/2010CN101668751A aspartyl protease inhibitors
03/10/2010CN101668749A Novel pyrimidine derivatives 698
03/10/2010CN101665466A Preparation method of quinazoline disulfide tetroxide derivative
03/09/2010US7674900 5,5'-bis(disubstitutedphosphino)-1,1',3,3'-tetraalkyl-4,4'-bipyrimidine-2,2',6,6'-(1H,1'H,3H,3'H)-tetrone used as as ligands to generate chiral transition metal catalysts, for asymmetric allylic substitution reactions
03/09/2010US7674809 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
03/09/2010US7674807 N-(1,1-dimethyl-2-methylsulfanyl-ethyl)-3-methanesulfonyloxy-phthalamic acid; 3-fluoro-N-(1-methyl-2-methylsulfanyl-ethyl)-phthalamic acid; effect against harmful insects without giving phytotoxicity on cultured plants
03/09/2010US7674795 Fluorene derivatives, composition containing said derivatives and the use thereof
03/09/2010US7674789 Compounds
03/04/2010WO2010025451A2 5,8-difluoro-4-(2-(4-(heteroaryloxy)-phenyl)ethylamino)quinazolines and their use as agrochemicals
03/04/2010WO2010024572A2 Material for organic photoelectric device and organic photoelectric device including the same
03/04/2010WO2010024430A1 2,4-diaminopyrimidine compound
03/04/2010WO2010023678A1 A process for preparation of rosuvastatin intermediate
03/04/2010WO2010023307A1 Novel urea and thiourea derivatives
03/04/2010WO2009025876A8 Crystalline forms of erlotinib hcl and formulations thereof
03/04/2010US20100056783 Novel Process for the Preparation of Statins and their Pharmaceutically Acceptable Salts thereof
03/04/2010US20100056551 Anti-cancer cyclopenta [G] quinazoline compounds
03/04/2010US20100056534 Pesticidal compositions
03/04/2010US20100056526 3-(4-Isopropoxyphenyl)-2-methyl-5-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-6-propylpyrimidin-4(3H)-one; for hypertension, cardiac disease, arteriosclerosis, kidney disease, stroke, dyslipidemia, obesity, diabetes, nonalcoholic steatohepatitis, dementia and/or Alzheimer's diseas
03/04/2010US20100056524 Compound
03/04/2010US20100056517 Arylsulfonamide compounds
03/04/2010US20100056506 Substituted 2-amino-fused heterocyclic compounds
03/04/2010US20100056377 Agent for inhibiting cytokinin signaling
03/04/2010US20100055687 Mutations in the BCR-ABL tyrosine kinase associated with resistance to ST1-571
03/04/2010US20100055116 Methods and Compositions for Targeting c-Rel
03/04/2010CA2735730A1 2,4-diaminopyrimidine compound
03/04/2010CA2735373A1 Novel urea and thiourea derivatives
03/03/2010EP2159216A1 Ih - Modulators
03/03/2010EP1572249B1 Solid-phase fluorination of uracil
03/03/2010EP1389183B1 Sulfonamide derivatives
03/03/2010EP0852499B1 Therapeutic azide compounds
03/03/2010CN101659642A Method for synthesizing sulfonylureas compound under phase-transfer catalysis
03/02/2010US7671200 2-(1-Aroylaminoalkyl)-3-(alkylaryl)-7-(halo- or cyano)quinazolinone derivatives, e.g., 2-[1'-(N,N-dimethylethylenediamino)propyl]-3-benzylquinazolin-4-one; mitotic kinesin spindle protein inhibitors; disrupting mitosis; modulating mitotic spindle formation; restenosis
03/02/2010US7671074 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others; N-{amino-[pyridin-2-yl-methyl)-amino]-methylene}-4-methylbenzenesulfonamide
03/02/2010US7671063 2,4 Di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitors
03/02/2010US7671036 Positively-charged peptide nucleic acid analogs with improved properties
03/02/2010US7670991 Substituted benzoylcyclohexenones and their use as herbicidal agents
02/2010
02/25/2010WO2010022128A1 Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
02/25/2010WO2010022126A1 Azo-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
02/25/2010WO2010022125A1 Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
02/25/2010WO2010022121A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
02/25/2010WO2010020432A2 Compounds for treatment of duchenne muscular dystrophy
02/25/2010WO2009158571A8 Heteroaryl compounds and uses thereof
02/25/2010WO2009155001A3 Wnt protein signalling inhibitors
02/25/2010WO2009137797A3 Quinazoline derivatives
02/25/2010WO2009133379A8 Dihydroorotate dehydrogenase as antifungal drug target and quinazolinone-based inhibitors thereof
02/25/2010WO2009110985A3 Amide compounds, compositions and uses thereof
02/25/2010US20100048900 Agent for treatment of vascular leaks
02/25/2010US20100048899 Process for preparing rosuvastatin calcium
02/25/2010US20100048898 Process for Synthesizing 7-Alkynyl-4- Aminoquinazolines and a Related Intermediate
02/25/2010US20100048893 Substituted arylalkanoic acid derivatives and use thereof
02/25/2010US20100048891 Metasubstituted thiazolidinones, their manufacture and use as a drug
02/25/2010US20100048593 Deazaflavin compounds and methods of use thereof
02/25/2010US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
02/25/2010US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
02/25/2010US20100048567 Inhibitors of syk and JAK protein kinases
02/25/2010US20100048561 Quinazolines for pdk1 inhibition
02/25/2010US20100048540 Heterocyclic N-Oxides as Hypoxic Selective Protein Kinase Inhibitors
02/25/2010CA2734489A1 Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
02/25/2010CA2734488A1 Azo-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
02/25/2010CA2734487A1 Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
02/25/2010CA2734486A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
02/24/2010EP2155695A1 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
02/24/2010EP2155692A1 Non-nucleoside reverse transcriptase inhibitors
02/24/2010EP2155675A1 Kinase inhibitors, compositions thereof, and methods of use therewith
02/24/2010EP2155656A2 Process for the preparation of gefitinib
02/24/2010EP2155194A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
02/24/2010EP2154967A1 Pyrimidine derivatives
02/24/2010EP1515954B1 Method for producing 4,6-dichloro-5-fluoropyrimidine
02/24/2010EP1465631B1 Pyrimidine a2b selective antagonist compounds, their synthesis and use
02/24/2010EP1000999B1 Compounds for organic el devices and organic el devices
02/24/2010CN101657431A Pyrimidine-2,4-diamine derivatives and their use as JAK2 kinase inhibitors
02/24/2010CN101654453A Process for the manufacture of the calcium salt of rosuvatatin and crystalline intermediates thereof
02/24/2010CN101654441A Anticoagulant compound, composition and application thereof
02/24/2010CN101654440A Method for synthesizing vitamin B1 derivative dithio-thiamin
02/24/2010CN101654439A Ortho-position dihalogen substitution compound of aryl pyrimidine and preparing method thereof
02/23/2010US7666895 adduct comprising a molecule binding with a kinase; antiinflammatory agents; modulating activation state of p38 kinase protein; switch control ligands to induce or restrict conformation
02/23/2010US7666873 N-phenyl-(2R,5S)dimethylpiperazine derivative
02/23/2010CA2335461C Calcium channel blockers
02/18/2010WO2010019473A1 Aurora kinase modulators and methods of use
02/18/2010WO2010018895A1 Process for the preparation of n-phenyl-2-pyrimidine-amine derivatives
02/18/2010WO2009024989A3 A novel hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form b
02/18/2010US20100041687 Hydrobromide salt of an anti-hiv compound
02/18/2010US20100041684 Pyrimidyl derivatives as protein kinase inhibitors
02/18/2010US20100041683 Novel chain-breaking antioxidants
1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 427